<DOC>
	<DOCNO>NCT00546403</DOCNO>
	<brief_summary>The purpose study test effect modafinil negative symptom , blunt affect social withdrawal , schizophrenic patient determine modafinil 's effect excessive daytime sleepiness . A secondary purpose study examine effect modafinil cognitive functioning schizophrenic patient .</brief_summary>
	<brief_title>Modafinil Augmentation Therapy Excessive Daytime Sleepiness Negative Symptoms Patients With Schizophrenia</brief_title>
	<detailed_description>Twenty six male patient schizophrenia ( twelve Excessive Daytime Sleepiness twelve without ) enrol San Diego Veterans Affairs Medical Center . Modafinil show increase alertness individual pathologically sleepy ( Study C1538a/301/NAIUS ) . Subjects randomized 1:1 ratio , stratify excessive daytime sleepiness ( value &gt; =9 Epworth Sleepiness Scale ) . Subjects receive either modafinil placebo , supply sponsor . The study drug take mouth daily morning . The titration schedule follow : 1 . The begin 50mg 2 week 2 . The study medication increase 100mg week 2 study visit 3 . The study medication increase 200mg week 4 study visit continue remain 4 week study . If subject unable tolerate dosage increase , dose decrease previous level .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Subjects must able communicate give voluntary inform consent Subjects must male gender Between age 18 65 year . A diagnosis Schizophrenia Schizoaffective disorder determine DSMIV criterion . Not conservatorized A negative symptom score PANSS &gt; = 20 MMSE score &gt; 24 No clinical evidence current unstable medical illness No current clinical evidence past history cerebral neurological impairment ( include stroke , tumor trauma leading loss consciousness ) No history drug alcohol dependence past 2 year No evidence drug alcohol abuse past year , determine DSMIV criterion . No diagnosis Narcolepsy determine DSMIV criterion Must approve contact person duration study May stable dose SSRI depressive symptom No history aggression No uncontrolled hypertension , define ( subject follow ) : 1. new diagnosis hypertension , 2. change antihypertensive medication past 30 day , 3. acute hypertension ( systolic &gt; 160mmHg , diastolic &gt; 100mmHg ) Maybe stable dose benzodiazepine The following medication allow study methylphenidate , amphetamine , pemoline , zolpidem , MAO inhibitor , anticoagulant , TCA 's , barbiturates . Be stable atypical neuroleptic May stable anticonvulsant mood stabilization Subjects female .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Excessive Daytime Sleepiness</keyword>
</DOC>